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logical toxicity: 8pts (cycloporine toxicity /CNS bleeding/ neu-
rotoxoplasmosis). Acute GVHD: grade III-IV: 4/15pts and
C-GVHD extensive: 5/11pts. Six pts had EBV reactivation and
4pts developed disease associated symptoms(2pts: high grade
NHL). 16 pts died between 7-120 days after UCBT(M: 47d).
Causes of death were mainly related to severe bacterial and
fungal infections. TRM: 44%. Overall survival for pts with good
HLA compatibility(5/6 or 6/6) was 56% compared to 28% after
a 4/6 UCBT (p:0.22). Conclusions: CYFLUATG im-
proved the survival of pts receiving a 5/6 or 6/6 UCBT. In
developing countries most pts have been exposed to CMV,EBV
or toxoplasmosis and close monitoring of viral reactivation as
well as aggressive treatment of bacterial infections are necessary
in order to decrease TRM. In this group,4/6 UCBT was asso-
ciated with a high incidence of rejection and TRM but the
survival did not reach statistical signiﬁcance probably due to the
small number of pts.
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Background: Fractionated total body irradiation (TBI) as condi-
tioning in allogeneic hematopoietic cell transplants (HCT) for
hematologic malignancies results in successful donor cell engraft-
ment and disease-free survival. However, standard TBI is associ-
ated with early organ toxicities and late impairment of growth,
development and endocrine function, especially in children. We
have previously shown that modiﬁed single-dose (SD) TBI condi-
tioning was well tolerated and successful in achieving engraftment
in adults.
Method: To decrease radiation-induced toxicity, SD TBI was
adopted for conditioning in pediatric hematologic malignancies. A
low total dose (550 cGy) was delivered at a high dose rate (30
cGy/min) after cyclophosphamide (60 mg/kg x2) followed by stem
cell infusion. GVHD prophylaxis included cyclosporine and short
course methotrexate. Methylprednisolone was included for URD
HCT.
Results: Since 1998, 57 children were transplanted using this
regimen. Recipient demographics are described in Table 1. Over
half were either in second remission or beyond, and had high risk
disease. Bone marrow was the stem cell source in 72%; 63% were
URD HCT. Median follow-up was 14 months (range 1-68).
Transplant outcomes are described in Table 1.
All patients, even when heavily pre-treated, tolerated the condi-
tioning well. Acute toxicities included grade 3-4 mucositis (21%),
invasive infections (11%), veno-occlusive disease (4%), renal fail-
ure (4%), multiorgan failure/shock (12%) and hemolytic anemia
(7%). The 100-day TRM was low (12%). The non-relapse mor-
tality after day 100 was 6%. Graft rejection and acute and chronic
GVHD rates were low (Table); GVHD-induced mortality was 7%.
There was no graft rejection after day 100. OS and DFS at one year
were 59% and 46%, thus comparable with standard TBI-based
conditioning. Immune reconstitution (determined by T and B cell
numbers and function) returned to normal range at one year post
HCT in the absence of GVHD.
Conclusions: SD TBI was well tolerated and supported donor
cell engraftment with low rates of GR, TRM and GVHD, even in
children with heavily pre-treated disease. Early OS and DFS were
comparable to standard TBI-based conditioning. This approach is
hence worthy of a larger trial in children with longer follow up to
compare late toxicities and DFS.
Table 1: Recipient Demographics and Outcome
Total patients 57
Median age (years) 11.3 (1.0-20.5)
Male/Female 40 (70%)/17 (30%)
Acute lymphoblastic leukemia 34 (60%)
Acute myelogenous leukemia 17 (30%)
Non-Hodgkin’s lymphoma 6 (10%)
CR1/ CR2/ CR3 37%/53%/9%
Refractory disease 1 (2%)
Bone marrow/ Peripheral blood 41 (72%)/16 (28%)
Matched sibling donor 21 (37%)
6/6 antigen/allele matched
unrelated donor (URD) 24 (42%)
5/6 matched URD 12 (21%)
Follow up (months) 14 (1-68)
ANC>500/dl: platelets>20,000/dl
(days) 13 (9-22): 18 (7-49)
Day 100 donor chimerism:
full/mixed/none 78%/ 11%/ 11%
Treatment-related mortality (TRM)
(day 100) 12%
Grade 2-4 aGVHD/ cGVHD
26% (CI 15-37%)/
40% (CI 28-52%)
Overall survival (OS) (1 year) 59% (CI 44-70%)
Disease-free survival (DFS) (1 year) 46% (CI 32-58%)
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Pulmonary complications cause signiﬁcant morbidity in the acute
stem cell transplant (SCT) period. Early identiﬁcation of a pulmo-
nary process can lead to earlier intervention and potentially im-
proved survival. The choice of a pulmonary imaging modality
should provide accurate and useful diagnostic information in a
timely manner. A chest radiograph (CXR) is frequently used when
investigating a pulmonary process as it can be rapidly obtained in
the transplant room without the need for sedation. Chest com-
puted tomography (CT) scans have greater accuracy than a CXR.
However, a chest CT scan may not be able to be immediately
obtained, may require sedation and cannot be done in the trans-
plant room. We investigated the diagnostic utility of chest CT
scans compared with CXR during the initial SCT admission. We
performed a retrospective review of all pediatric SCT performed at
our institution between January 1, 2004 and September 1, 2006. Of
the 194 patients transplanted 34 (17.5%) had a total of 60 chest
CTs during the initial transplant admission. Indications for chest
CT were pulmonary symptoms without fever (33.3%), follow-up
of previous radiographic study (15%), neutropenic fever (13.3%),
non-neutropenic fever (11.7%), non-neutropenic fever with pul-
monary symptom (11.7%), neutropenic fever with pulmonary
symptom (8.3%), chest pain (5%), and abdominal pain (1.7%). 49
patients also had a CXR performed within 72 hours of their CT. 36
scans were performed within 72 hours of a normal CXR. 22
(61.1%) of these provided new diagnostic information, including:
new airspace disease or opacity (19 scans), new pleural effusion or
signiﬁcant difference in size of effusion (4 scans), new pericardial
effusion (3 scans), and a new epipericardial mass (1 scan). Of the
CT scans with a new diagnosis following a normal CXR, 81.8%
were made in patients with pulmonary symptoms. 14 (38.9%) of
the CTs done within 72 hours of normal CXR were normal. 13 CT
scans were done within 72 hours of an abnormal CXR. 12 of these
had an abnormal CT scan which provided more detail, but no new
diagnoses. The remaining CT was within normal limits in the
setting of an abnormal CXR. CXR and chest CT are useful diag-
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